Egfr Mutation | List of Frontiers open access articles

Original Research

Published on 22 Mar 2021

Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer

in Thoracic Oncology

Xinyu Zhang
Chun Li
Maosong Ye
Qin Hu
Jie Hu
Ziying Gong
Jieyi Li
Xiaokai Zhao
Yiqing Xu
Daoyun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.602402

5,584 views
10 citations

Original Research

Published on 21 Feb 2022

Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers

in Cancer Immunity and Immunotherapy

Youming Lei
Kun Wang
Yinqiang Liu
Xuming Wang
Xudong Xiang
Xiangu Ning
Wanbao Ding
Jin Duan
Dingbiao Li
Wei Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2022.811601

9,897 views
17 citations

Original Research

Published on 09 Jan 2020

The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma

in Thoracic Oncology

Wei Zhao
Yuzhi Wu
Ya'nan Xu
Yingli Sun
Pan Gao
Mingyu Tan
Weiling Ma
Cheng Li
Liang Jin
Yanqing Hua

Frontiers in Oncology

doi 10.3389/fonc.2019.01485

8,023 views
51 citations

Original Research

Published on 25 Sep 2019

Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma

in Thoracic Oncology

Xueling Qu
Qiuwen Li
Jingwen Yang
Huixia Zhao
Feifei Wang
Fengyun Zhang
Shufang Zhang
He Zhang
Ruliang Wang
Qian Wang

Frontiers in Oncology

doi 10.3389/fonc.2019.00931

6,135 views
45 citations

Original Research

Published on 24 Jan 2022

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer

in Thoracic Oncology

Chi-Lu Chiang
Chia-I Shen
Hsu-Ching Huang
Han-Jhih Chang
Yu-Ting Huang
Chao-Hua Chiu

Frontiers in Oncology

doi 10.3389/fonc.2022.810124

2,204 views
5 citations

Original Research

Published on 27 Apr 2022

PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features

in Pharmacology of Anti-Cancer Drugs

Weicheng Huang
Jingyi Wang
Haolin Wang
Yuxiang Zhang
Fengjun Zhao
Kang Li
Linzhi Su
Fei Kang
Xin Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.898529

6,419 views
34 citations

Original Research

Published on 18 Jul 2019

Correlations Study Between 18F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma

in Cancer Imaging and Image-directed Interventions

Bin Yang
Qing gen Wang
Mengjie Lu
Yingqian Ge
Yu jun Zheng
Hong Zhu
Guangming Lu

Frontiers in Oncology

doi 10.3389/fonc.2019.00589

4,393 views
17 citations

Case Report

Published on 09 Aug 2024

Long term survival achieved through combination of almonertinib and pyrotinib in EGFR-mutant/HER2-amplified advanced NSCLC patient: a case report and literature review

in Thoracic Oncology

Xin Pan
Xiao Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1397238

2,883 views
2 citations

Original Research

Published on 22 Mar 2021

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

in Thoracic Oncology

Liang Shi
Junfang Tang
Hong Tao
Lili Guo
Weihua Wu
Hongbo Wu
Zichen Liu
Li Tong
Wei Wu
Hongxia Li

Frontiers in Oncology

doi 10.3389/fonc.2021.622142

4,513 views
12 citations

Original Research

Published on 02 Oct 2025

Deep learning on brain metastasis for predicting EGFR genotype and EGFR-TKI therapy response in metastatic NSCLC: a multicenter study

in Biosensors and Biomolecular Electronics

Shuailin You
Ying Fan
Zhiguang Yang
Chunna Yang
Yiyao Sun
Yahong Luo
Zekun Wang
Bo Sun
Wenyan Jiang

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2025.1637095

3,878 views
1 citation

Original Research

Published on 16 Dec 2021

A Computed Tomography-Derived Radiomics Approach for Predicting Uncommon EGFR Mutation in Patients With NSCLC

in Thoracic Oncology

Wufei Chen
Yanqing Hua
Dingbiao Mao
Hao Wu
Mingyu Tan
Weiling Ma
Xuemei Huang
Jinjuan Lu
Cheng Li
Ming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.722106

2,902 views
6 citations

Original Research

Published on 22 Jul 2021

Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

in Thoracic Oncology

Guotao Yin
Ziyang Wang
Yingchao Song
Xiaofeng Li
Yiwen Chen
Lei Zhu
Qian Su
Dong Dai
Wengui Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.709137

5,679 views
40 citations

Case Report

Published on 26 Nov 2025

Case Report: Two cases of non-small cell lung cancer with coexistence of NTRK2 fusion and EGFR mutations

in Cancer Molecular Targets and Therapeutics

Yuping Zhang
Hengming Zhang
Xiufeng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1664782

1,710 views

Original Research

Published on 08 Oct 2020

Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients

in Cancer Molecular Targets and Therapeutics

Haiyan E. Liu
Meghah Vuppalapaty
Charles Wilkerson
Corinne Renier
Michael Chiu
Clementine Lemaire
James Che
Melissa Matsumoto
James Carroll
Steve Crouse

Frontiers in Oncology

doi 10.3389/fonc.2020.572895

12,090 views
52 citations

Original Research

Published on 23 Jun 2022

Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer

in Thoracic Oncology

Ruiyuan Yang
Xingyu Xiong
Haoyu Wang
Weimin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.924144

6,243 views
21 citations

Clinical Case Study

Published on 08 Dec 2014

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression

in Thoracic Oncology

Katrijn Van Assche
Liesbeth Ferdinande
Yolande Lievens
Katrien Vandecasteele
Veerle Surmont

Frontiers in Oncology

doi 10.3389/fonc.2014.00350

35,472 views
14 citations

Articles

Bronchial Washing Fluid Versus Plasma and Bronchoscopy Biopsy Samples for Detecting Epidermal Growth Factor Receptor Mutation Status in Lung Cancer

Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers

The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma

Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer

PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features

Correlations Study Between 18F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma

Long term survival achieved through combination of almonertinib and pyrotinib in EGFR-mutant/HER2-amplified advanced NSCLC patient: a case report and literature review

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

Deep learning on brain metastasis for predicting EGFR genotype and EGFR-TKI therapy response in metastatic NSCLC: a multicenter study

A Computed Tomography-Derived Radiomics Approach for Predicting Uncommon EGFR Mutation in Patients With NSCLC

Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

Case Report: Two cases of non-small cell lung cancer with coexistence of NTRK2 fusion and EGFR mutations

Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients

Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression